Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Advaxis Zips Listeria/Opdivo Combo Straight To Registrational Cervical Cancer Trial

May 31 2017

• By Emily Hayes

Cancer-cells-pink-color_1200x675

Related Content

China, Emerging Markets In Focus For Genentech On Broad <em>Avastin</em> Access In Cervical Cancer

Sep 03 2014

Advaxis Immunotherapy Boosts 12-Month Survival In Cervical Cancer

Sep 18 2015

Advaxis to fund combination trial with AstraZeneca's MEDI4736

Jul 22 2014

Related Companies

Advaxis, Inc.

Bristol Myers Squibb Company

INSYS Therapeutics, Inc.

Iovance Biotherapeutics, Inc.

Puma Biotechnology, Inc.

AstraZeneca PLC

Roche Holding AG

Additional Topics

Research & Development ImmunoOncology Clinical Trials Deals Gynecology & Urology BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window